Trial Profile
The effects of ezetimibe on malondialdehyde-modified low-density lipoprotein in abnormal glucose tolerance patients with coronary artery disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Atorvastatin
- Indications Coronary artery disease; Diabetes mellitus; Hyperlipidaemia
- Focus Pharmacodynamics
- 20 Feb 2011 New trial record